Received 510(k) clearance then commenced limited market release after performing first surgeries using the Integrity Implant System.
Completed enrollment in Hyalofast® pivotal Phase III clinical study, a key milestone in its path to achieving US FDA approval.
Tactoset® received additional FDA 510(k) clearance to be combined with autogenous bone marrow aspirate (BMA).
Commenced full market release of X-Twist Fixation System, a cornerstone product in Anika’s Sports Medicine portfolio.